Back to the Top
Pharsight announces the release of Drug Model Explorer version 1.6.
DMX is a software visualization and communication tool to explore
model-based results of a compound's product profile.
The new release features a modified user interface and new
functionality to more prominently visualize probabilistic predictions
of one or more clinical endpoints reaching a specified performance
target, with a product profile defined as a collection of endpoint
DMX results are presented as a series of plots and tables based on
pre-simulated models of clinical effect, and are accessible from
networked desktop or laptop computers.
Please access the following link for more details about DMX: http://
Please send all responses or inquiries to Pharsight Corporation, at
Want to post a follow-up message on this topic?
If this link does not work with your browser send a follow-up message to PharmPK@boomer.org with "Pharsight Drug Model Explorer 1.6 Released" as the subject
Support PharmPK by using the
Copyright 1995-2011 David W. A. Bourne (firstname.lastname@example.org)